As we aim to establish Padagis as a leader in the generics market, business development and acquisitions remain at the center of our strategy. Our business development efforts are focused on driving growth by expanding our product portfolio through strategic partnerships.
Collaborate With Padagis
As we aim to establish Padagis as a leader in the generics market, business development and acquisitions remain at the center of our strategy. Our business development efforts are focused on driving growth by expanding our product portfolio through strategic partnerships.
OUR KEY BUSINESS DEVELOPMENT INITIATIVES INCLUDE:
PRODUCT ACQUISITION & LICENSING
Acquiring or licensing approved, filed, or near-to-filing products in nasal, topical, and oral dosage forms that we can manufacture and commercialize through our existing infrastructure or any other dosage forms (including ophthalmic, transdermal, and retail injectables), where we can leverage our partner’s manufacturing network.
CO-DEVELOPMENT
Partnering with integrated development and manufacturing companies for complex generics.
PRIVATE LABEL
Working with private label companies to expand the reach of our commercialized product portfolio in the US.
MARKET EXPANSION
Expanding our existing product portfolio in international markets including Europe, Canada, and Latin America.
CONTRACT MANUFACTURING
Supporting branded and specialty pharmaceutical companies by end-to-end manufacturing of nasal and topical dosage forms at our state-of-the-art manufacturing facilities located in Israel and the US.
